Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in endogenous insulin and glucagon secretion during basal insulin substitution with Lantus
2008-002117-46Phase 4Active
- Sponsor
- St. Josef-Hospital Bochum - Medizinische Klinik I
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by St. Josef-Hospital Bochum - Medizinische Klinik I. Primary endpoint: First-phase insulin secretion after basal insulin supplementation with matched fasting glucose. Started May 2008; status: active.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002117-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002117-46.